Eosinophils like many myeloid innate immune cells can provide cytokines and chemokines for the activation of other immune cells upon TLR stimulation. When TLR-stimulated eosinophils were inoculated i.p. into wild-type mice, and NK cells were rapidly recruited and exhibited antitumour cytotoxicity. However, when mice depleted of CD11c + cells were used, a marked decrease in the number of recruited NK cells was observed. We postulated that CpG or LPS from the injected eosinophils could be transferred to host cells, which in turn could recruit NK cells. However, by inoculating mice deficient in TLR4 or TLR9 with LPS or CpG-stimulated eosinophils respectively, NK cell recruitment was still observed alongside cytotoxicity and IFNc production. CpG stimulation of eosinophils produced the pro-inflammatory cytokine IL-12 and the chemokine CXCL10, which are important for NK cell activation and recruitment in vivo. To demonstrate the importance of CXCL10 in NK cell recruitment, we found that CpG-stimulated eosinophils pretreated with the gut microbial metabolite butyrate had reduced expression and production of CXCL10 and IL-12 and concomitantly were poor at recruitment of NK cells and inducing IFNc in NK cells. Therefore, eosinophils like other innate immune cells of myeloid origin can conceivably stimulate NK cell activity. In addition, products of the gut microbiota can be potential inhibitors of NK cell.
Introduction
Eosinophils are thought to have a primary role in host defence against parasite infection and immunopathology in T H 2-type inflammation [1] . However, eosinophils are also effector cells with cytotoxic capabilities and have the potential to induce T H 1-type inflammation [1] . For example, activated eosinophils are observed in cancers, and the deposition of eosinophil products is readily seen in the affected tissues [2] . Thus, eosinophils may play an active role in other immune responses apart from those against parasites and in T H 2-type inflammation.
NK cells are the major lymphocyte population within the innate immune system, and play a role in host defence against pathogens as well as in malignancies. In recent years, it has become clear that NK cells require accessory cells to become activated. Both conventional and plasmacytoid dendritic cells (DCs) can induce recruitment of NK cells to sites of infection, and production of IFNa and IL-15 from these cells plays a role in their activation [3] [4] [5] [6] [7] . However, it is clear that other innate immune cells can also cross-talk with NK cells and may play critical roles in host defence. Recent studies have demonstrated a role for neutrophils in not only homeostasis but also in activating NK cells [8] [9] [10] . Indeed cross-talk between DCs, NK cells and neutrophils were found to be important in developing adaptive immune responses [10] . Macrophages and monocytes can also activate NK cells by releasing proinflammatory cytokines such as IL-12 and IL-18 [11] . In addition, bone marrow-derived mast cells have also been found to activate NK cells upon TLR stimulation [12] .
To date, studies examining NK cell-eosinophil interaction have focused on how NK cells affect eosinophil function [13] [14] [15] , but no studies have examined how eosinophils affect NK cell-mediated responses. In the present study, eosinophils were examined for the ability to recruit and activate NK cells in vivo following TLR-ligand stimulation.
Materials and methods
Mice. C57BL/6, TLR4 À/À [16] and TLR9 À/À [17] were housed under specific pathogen-free conditions at the animal facility of Department of Microbiology, Tumor and Cell Biology. CD11c.DTR mice were housed at the animal facility of the Department of Medicine Huddinge [18] . Procedures were performed under both institutional and national guidelines (permission number N339/09 and N147/15). Generation of BM eosinophils. Eosinophils were generated by ex vivo culture of mouse bone marrow cells using the method previously described by Dyer et al. [19] . BM cells were seeded at 1 9 10 6 cells/ml and cultured in RPMI 1640 medium (HyClone â , South Logan, UT) supplemented with 10% foetal bovine serum (Biowhittaker â , Verviers, Belgium), 250 IU/ml penicillin and streptomycin solution, 2 mM glutamine, 50 mM HEPES, 1 9 nonessential amino acids and 1 mM sodium pyruvate (HyClone â ), and 50 lM b-mercaptoethanol (Gibco â , Paisley, UK) and supplemented with 100 ng/ml recombinant mouse stem cell factor and 100 ng/ml recombinant mouse FLT3 ligand (ImmunoTools, Friesoythe, Germany). After 4 days, fresh medium containing 10 ng/ml recombinant mouse IL-5 (ImmunoTools) was added, and thereafter, the medium was replaced every second day with fresh medium containing rmIL-5 for 10 days. Eosinophils were purified using anti-CD11b beads and magnetic sorting (Miltenyi Biotech) and purity measured by flow cytometry (Fig. 1A) . Cells were then stimulated as described.
NK cell recruitment assay. Purified eosinophils were stimulated for 4 h with 500 ng/ml LPS (Sigma-Alrdrich, Stockholm, Sweden) or 500 nM CpG 2216 (Invivogen, San Diego, CA, USA). The cells were washed three times in PBS and injected i.p into adult mice (6-14 weeks old) at 4 9 10 5 cells/mouse in a volume of 100 ll. Donor cells were sex matched with recipients. Cells were harvested by peritoneal lavage with PBS after 48 h, and stained with antibodies for multicolour flow cytometry. In DC depleting studies, CD11c-DTR mice were depleted by i.p injection of 4 ng of Diphteria toxin (Sigma)/g body weight [18] . Depletion of DCs was checked by staining for CD11c high MHC-II+ cells in the spleen, and >96% reduction of DCs was confirmed ( Figure S1 ). For studies using butyrate, the cells were pre-incubated for 2 h with 2 mM butyrate and then CpG-stimulated for 4 h. Cytokine detection. Cells were cultured at 1 9 10 6 ml in 48-well plates overnight with the appropriate stimulation. CXCL10, IL-6 and IL-12p70 ELISAs were performed according to manufacturers guidelines (RNDsystems for CXCL10 and eBioscience for IL-6 and IL-12p70).
Flow cytometry. All antibodies were purchased from eBioscience (San Diego CA) or Biolegend (San Diego CA): clones used were anti-CCR3 (J073E5) APC, -CD3 (145.2C11) labelled with FITC or PerCp-Cy5.5, -CD11b (M1/70.15) FITC, -CD11c (N418) PE, -IFNc (XMG1.2) PerCp-Cy5.5, -NKp46 (29A1.4) APC and -Siglec F (1RNM44N) PE. All surface staining was performed in phosphate-buffered saline (PBS) after blocking unspecific staining via FccRII/III with purified anti-CD16/32 antibody (2.4G2). Flow cytometry on peritoneal washes was performed on FACSSort (BD Biosciences, San Diego CA), and 1 9 10 4 lymphocytes were collected for analysis (Fig 1B) . Flow cytometry on the eosinophils was performed on CyAN ADP LX 9-colour flow cytometer (Beckman Coulter, Pasadena, CA). Data were analysed using FlowJo software (Tree Star Inc, OR).
For intracellular staining for IFNc, cells were stimulated for 2 h with PMA (50 ng/ml) and ionomycin (1000 ng/ml) (Sigma-Aldrich) after which time point monensin and brefeldin A (Biolegend) were added 1:1000 to the cultures, and the cells were cultured for further 2 h. In NK celleosinophil co-cultures, eosinophils were stimulated overnight with CpG, washed and then mixed with NK cells at a 1:1 ratio. Monensin and brefeldin A were added 2 h after the start of the co-incubation. After surface staining, the cells were fixed in 2% formaldehyde for at least 30 min before being permeabilized using permeabilization buffer (Biolegend) and incubated with anti-IFNc antibodies at room temperature in the dark for 30 min.
Cytotoxicity assays. YAC1 tumour cells were incubated for 1 h in the presence of Na 2 O 4 Cr 51 (Amersham, Oxford UK) and then washed thoroughly in PBS. DX5-sorted cells from the peritoneal cavity were mixed with the tumour cells at a ratio of 10:1 to measure killing. After 4 h, cell culture supernatants were analysed on a gamma radiation counter (Wallac Oy, Turku, Finland). Specific lysis was calculated according to the formula: % specific lysis = (experimental release-spontaneous release)/(maximum release-spontaneous release) 9 100.
Statistical analysis. All statistical analysis was performed using GraphPad Prism software (La Jolla, CA).
Results

TLR-stimulated eosinophils recruit NK cells to the peritoneal cavity
The peritoneal cavity can be used as a model for NK cell recruitment and activation in vivo following i.p. injection of conventional (cDC) and plasmacytoid dendritic cells (pDC) and tumours [4, 20] . Purified bone marrow (BM)-derived eosinophils were stimulated with LPS or CpG and injected i.p. to determine whether eosinophils could induce NK cell recruitment and activation. Fortyeight hours post-inoculation, the frequency of NK cells increased in the peritoneal cavities of mice receiving CpGstimulated eosinophils (17 AE 5.9% versus 4 AE 1.4% in mice receiving control eosinophils, n = 10-12 mice P < 0.05 Mann-Whitney test, Fig. 1C) . In all these experiments, we found that this increased frequency was related to increased numbers of NK cells in the peritoneum and not due to loss of other cell types (Fig. 1C) . The frequency of recruited NK cells by CpG-stimulated eosinophils was comparable to that observed in mice that had been injected with CpG-stimulated DC (19.8 AE 1.4% NK cells n = 8-10 mice). LPS-stimulated eosinophils also induced an increased NK cell frequency in the peritoneum (12.3 AE 5.1% versus control eosinophils 4.4 AE 1.6 P < 0.05 Mann-Whitney test). high CpGstimulated eosinophil recipients, P < 0.05 Mann-Whitney test, n = 7-9 mice) suggesting that the eosinophils could also attract DC or inflammatory macrophages. To determine the role of CD11c high cells in co-operating with eosinophil-mediated recruitment of NK cells, we inoculated CD11c.DTR mice with CpG-stimulated eosinophils i.p. CD11c.DTR mice depleted of CD11c + cells by pretreatment with diphtheria toxin exhibited a significant reduction in the frequency of NK cells recruited by the CpG-stimulated eosinophils (22.7 AE 6.3% versus 9.9 AE 4.4% NK cells, n = 4-5, P < 0.05 Mann-Whitney test Fig. 1D ). This suggested that host DC or inflammatory macrophages amplify the recruitment of NK cells by eosinophils.
As we observed reduced NK cell recruitment in mice depleted of CD11c + cells, this suggested that these cells could be stimulating the recruitment of NK cells by taking up LPS or CpG released from eosinophils or through crosspriming by taking up dying eosinophils. To rule out LPS and CpG from injected cells being transferred to host cells and stimulating them, we injected TLR4 À/À and TLR9 
NK cells recruited by eosinophils are cytotoxic
To test if the NK cells in the peritoneum were also functional, DX5 + NK cells were purified from the peritoneal cavities of mice injected with CpG-stimulated eosinophils and tested for the ability to kill YAC1 tumour cells. NK cells from wild-type mice injected with control eosinophils exhibited little or no killing (Fig. 2C) . However, NK cells from both wild-type and TLR9
À/À mice that received CpG-stimulated eosinophils both exhibited killing of YAC1. This demonstrated that TLR-activated eosinophils could also induce NK cell-mediated cytotoxicity.
TLR-ligands can induce pro-inflammatory cytokines by eosinophils, but this is inhibited by short chain fatty acids
Stimulation of TLR9 can induce pro-inflammatory cytokines such as IL-6, CXCL10, a critical chemokine for the recruitment of NK cells by DC [4, 21] , and IL-12, which induces IFNc from NK cells. By ELISA, we found the CpGstimulation induced IL-6, IL-12p70 and CXCL10 in the bone marrow-derived eosinophils (Fig. 3A-C) . Coincubation of NK cells with CpG-stimulated eosinophils in vitro could induce IFNc in the NK cells, while control eosinophils did not induce IFNc in the NK cells (Fig. 4A,  B) . Similarly, CpG-stimulated eosinophils could induce IFNc in NK cells collected from the peritoneal cavity (Fig. 5B) . Short chain fatty acids (SCFAs) generated by the microbiota, for example butyrate, have been shown to have immuno-modulatory effects by inhibiting proinflammatory cytokines produced by DCs such as CXCL10 and IL-12 [22] [23] [24] . When eosinophils were pretreated with butyrate for 2 h prior to CpG stimulation, they produced reduced levels of IL-6, IL-12p70 and CXCL10 by ELISA (Fig. 3A-C) . This suggested that SCFAs could also dampen pro-inflammatory responses in eosinophils as they do in DCs. When CpG-stimulated eosinophils pretreated with butyrate were inoculated i.p. into TLR9 À/À mice, the frequency of NK cells recruited into the peritoneal cavity in the mice injected with CpG-stimulated eosinophils pretreated with butyrate was significantly reduced when compared to TLR9 À/À mice who received CpG stimulated only eosinophils (Fig. 5A, C) . In addition, IFNc levels in NK cells from mice inoculated with CpG-stimulated eosinophils treated with butyrate were significantly less than those levels observed in mice that received CpG-stimulated only eosinophils (Fig. 5B, D) . Thus, NK cell function could be affected by the reduction of pro-inflammatory responses caused by pretreatment of eosinophils with butyrate.
Discussion
Previous studies examining NK cell-eosinophil interactions have focused primarily on how NK cells control eosinophilia through cytokine secretion [13] [14] [15] . Scant attention has been directed at how eosinophils could affect NK cells, which is surprising because eosinophils have been found to function as antigen presenting cells [25] , modulate host defence against viral [26] [27] [28] and bacterial infections [29] [30] [31] , and produce cytokines and chemokines that would act on NK cells [25] . In the present study, we demonstrated that NK cells could be recruited and activated by eosinophils in vivo following TLR stimulation of eosinophils. In wild-type mice, NK cell recruitment appeared to be enhanced by co-operation with host CD11c + cells. However, using TLR4-and TLR9-deficient mice as hosts, we could rule out that passage of TLR ligands to host cells was involved in this NK cell recruitment. This demonstrated that eosinophils produced sufficient chemokines themselves to recruit NK cells. Mann-Whitney test (n = 6). We have previously demonstrated such cross-talk between pDCs and cDCs was important for NK cell activation [4] , and cross-talk between NK cells, DCs and neutrophils has also been found [10] . However, amongst innate immune cells, there could be some cross-talk with each other to enhance their responses not only through cytokine interaction but also through transfer of TLR-ligands. Crosspriming has generally been associated with transfer of proteins or peptides from cells to dendritic cells [32] , but we could also envisage cross-priming to include the transfer TLR-ligands from injected cells to host cells.
SCFAs are metabolites of gut microbiota, which possess anti-inflammatory effects [22] [23] [24] and may impact immune responses in not only the gut but also distally [33] . We found that eosinophils pretreated with butyrate 2 h prior to stimulation, also exhibited reduced levels of proinflammatory CXCL10 and IL-12. This suggests that not only DCs but also eosinophils, which lie along the gut, might be prevented from exhibiting pro-inflammatory responses to microbial products because of modulation by SCFAs. However, as previous studies have suggested that SCFAs entering the blood stream could affect cells outside the gut [33] , eosinophils in the periphery may also be affected in for example the lungs, which would explain how intestinal SCFAs could play a role in dampening allergic responses in the lungs.
Eosinophils can affect cancer development and play a key role in tumour rejection [2] . Eotaxin released by tumours recruits eosinophils, where they can have direct cytotoxic effects on malignant tissues by release of for example major basic protein [2] . Eosinophils can also aid in tumour rejection by recruiting T cells to the tumours as well as polarizing the tumour-associated macrophages [34] . As NK cells are also important in anti-cancer immune responses [35] , eosinophil-NK cell interactions could play a role in tumour eradication through recruitment and activation. However, it cannot be ruled out that SCFA levels in the periphery might also affect NK cell-eosinophil or NK cell-DC interactions, which might be detrimental to antitumour immune responses. Thus, understanding the networks within the innate immune system and how they are coupled to the microbiota will become increasingly important in designing future methodologies not only for modulating chronic inflammatory responses but also for tumour rejection.
